Correction: Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3.

Since the publication of this paper, the authors have noticed that the article contains an error in Figure 3e (TSN, 50 nM). As a result of the misfiling of the data, the incorrect image was inadvertently inserted in Figure 3e during figure preparation. The corrected image is shown in this correction.